FutureMeds

Heading to the 15th Operational Excellence in Clinical Trials Summit this year? Ninon Armbrust, Head of Sites at FutureMeds Geramany and Rebeca González Vicedo, Director of Decentralised Clinical Trials, will be joining the summit to meet familiar and new partners and to compare notes with peers. Following her engaging speaker session at EUCROF 25, Rebeca will get mic'd up again. If you are interested in exploring increasing study performance, join her session: 🎤 Decentralised Elements in Clinical Trials: Tools towards more impactful trials If you or your colleagues are attending and would like to connect, send Ninon and Rebeca a connection request or a message. We look forward to meeting you in Berlin and hope to start a dialogue with you. #ClinicalResearch #ClinicalTrials

Nachiket Chandak, Senior Director of Business Development, will be sharing insights on 2 panels at the Society for Clinical Research Sites (SCRS) European Site Solutions Summit. 🎤 Collective Action: Attracting More Clinical Studies To Europe | Breakout Session II 14:45 – 15:45 February 24 This session will explore what sites can do to showcase their capabilities in a way that will help them leverage their regional strengths and garner more traction. 🎤 Embracing Diversity & Inclusion In Research | Breakout Session III, 11:00 – 12:00 February 24 Join the session to gain insights into promoting diversity and inclusion initiatives that elevate research quality while ensuring ethical standards and compliance. Get to know Nach: Nach is a seasoned professional with over 17 years of experience in clinical development, specialising in business expansion and strategic growth. He has held key positions across industry-leading organisations, from strategic consulting firms to top CROs, where he has played a pivotal role in driving revenue and fostering partnerships. In his recent roles at Parexel, ICON, and PPD, Nach has focused on business expansion, successfully advancing Phase I-IV research initiatives. His expertise spans clinical development, strategic planning, and forging strong collaborations to accelerate research and innovation. At FutureMeds, Nach continues to contribute to the evolution of clinical research, leveraging his deep industry knowledge to drive growth and impact. #ClinicalTrials #ClinicalResearch

FutureMeds is a nominee for the 2025 Vaccine Industry Excellence (ViE) Awards We would be honoured if you would support us by casting your vote for FutureMeds in the Best Clinical Trial Network category. "Our vaccine trial work has evolved beyond operational excellence into something truly meaningful. It has helped us build a community of engaged patients across Europe who share our vision for advancing medical science," commented Wojciech Szczepanik, Executive VP of Operations "By learning from each vaccine season and strengthening our collaborative approach, we're not just running trials, we're creating a sustainable trial framework for supporting future innovation in vaccine development." Vote today: https://lnkd.in/e8ad9A_4 #ClinicalResearch #ClinicalTrials

FutureMeds Warsaw has successfully passed a recent FDA inspection.  The FDA inspector was pleased with the high standards the dedicated site team maintained and praised FutureMeds’ processes and documentation.  “I am grateful to work alongside experienced people who take their responsibilities seriously. The inspection showed what I see every day. A team that’s committed to running safe trials and looking after our patients well,” said Kurosz Justyna, Site Director This is FutureMeds’ second successful FDA inspection within the month.    A few weeks ago, FutureMeds Krakow also completed a successful inspection showcasing our commitment to quality.  But as said, the work is far from over. Our site teams and central support teams continue to improve collaboration to   - Further elevate the standards of our inspection-ready processes  - Reduce regulatory risk in clinical trials  - Protect data quality and integrity “I want to express my sincere gratitude to our Principal Investigator, Dr Izabella Gladysz, Site Director Justyna Kurosz, Head of Study Coordinators and Quality Coordinators Martyna Zdanowska and the entire team for their hard work and commitment. Your teamwork and attention to detail have been crucial in achieving this positive outcome,” added Inga Yankilevich, Senior Global Quality Manager #ClinicalResearch #ClinicalTrials 

Circle the dates. Iwona Tongbhoyai, Chief Client Solutions Officer, will be sharing insights on 2 panels at Society for Clinical Research Sites (SCRS) European Site Solutions Summit. If you are interested in joining a site network to increase your trial opportunities and support for your teams and PIs, the following session with fellow site network representatives might be for you: 🎤 Maximizing Opportunities: How To Join A Site Network | Breakout Session I 13:00 – 14:00 February 24    Want to have smoother collaboration between your European sites and US sponsors? Join the session below to hear about best practices and practical strategies for European sites in managing US-based stipends: 🎤 Transatlantic Transactions: Handling US-Based Stipends | Breakout Session IV, 11:00 – 12:00 February 25 Get to know Iwona: Iwona's mission is to bring the clinical industry stakeholders closer and help develop together the solutions needed for the industry, clients and patients. With over 16 years of Site and Clinical Trials Management background and more than 7 years of Business Consultancy experience, Iwona has a unique blend of expertise with a strong focus on strategic planning. She spent 6 years at one of the Global Dedicated Research Site Networks, where she was responsible for the Western Europe Region and then leading the global operational teams, improving the efficiency of the global start-up and clinical trial and site operational readiness across over 160 sites and 17 countries. At FutureMeds, she plays a key role in growing the site network and building lasting relationships with Sponsors and CROs. She specialises in DCTs and strives to help Sponsors and CROs develop and deploy strategies and solutions that positively impact research timelines and drive medical progress. #ClinicalTrials #ClinicalResearch

We asked our five colleagues what excited them about attending the Society for Clinical Research Sites (SCRS) European Site Solutions Summit this year. Our site teams will be represented by Rocio Diaz Sanchez, Managing Director of Spain, Angela Harnick, Site Director and Kinga Zajączkowska, Site Director, whose teams made significant progress over the years. As a speaker, Iwona Tongbhoyai, Chief Client Solutions Officer, will be contributing to the following sessions: 🎤 Maximizing Opportunities: How To Join A Site Network 🎤 Transatlantic Transactions: Handling US-Based Stipends Nachiket Chandak, Senior Business Development Director, will be adding value to the following discussions: 🎤 Embracing Diversity & Inclusion In Research 🎤 Collective Action: Attracting More Clinical Studies To Europe You can read their responses below. P.S. If you or your colleagues are attending and would like to connect, send our team a connection request or a message. We look forward to meeting you in Lisbon and hope to start a dialogue with you. #ClinicalResearch #ClinicalTrials

Dr Khaled Ahmed, Site Director at FutureMeds Birmingham, was recently handpicked as one of eight experts across the globe in a sponsor-led working group – proudly representing Team GB.    This working group has been devised for 2025 and onwards to shape the future of clinical trial diversity and community engagement from a trial-agnostic point of view.    “I didn’t realise we at FutureMeds Birmingham have made so much progress in this area, whereas others are only exploring initiatives that my team have already trialled and tested,” commented Dr Khaled Ahmed on his experience.    During the sessions, the group explored in detail:  - Community expectations from trial sponsors and study sites  - Listening to participant perspectives to inform trial design  - Developing funding application streams for more diverse recruitment  - The impact of AI in 21st-century clinical research  - Community engagement best practices—what’s working and what isn’t    “Being part of this esteemed group and the discussions reaffirm that the work we do can serve as a blueprint. It’s exciting to see our forward-thinking approach can shape best practices worldwide.”    We couldn’t be prouder of Khaled's work and his pioneering solutions that can benefit diverse patient communities across the globe.    #ClinicalTrials #ClinicalResearch Disclaimer: The picture below is from a previous, different sponsor event. The sponsor's logo has been edited out

An important year-long project came to completion.  Spearheaded by Nele Brennecke, Head of Patient Engagement at FutureMeds Germany, the project team brought each FutureMeds country’s website under a professional, cohesive framework. “By reimagining our patient-facing websites and related internal processes, we’ve created more than just modern digital interfaces, we’ve built bridges of understanding, accessibility, and hope. These improvements mean patients can now find critical information faster and navigate their clinical trial journey with greater ease,” added Wojciech Szczepanik, Executive VP of Site Operations The patient-centric design ensures every visitor can find critical clinical trial information more easily, driving both higher user satisfaction and better conversion performance. The results speak for themselves: Improved Patient Engagement: The first site launched in 2024 saw 1.2 million search impressions and 35,000 clicks Better Integration: Enhanced integration with the FutureMeds systems now helps us optimise recruitment while simplifying registration processes, reducing barriers to participation Stronger Trial Reputation: The updated websites enhances confidence and trust in FutureMeds and is better suited to amplify the voice of patients and the work our teams do in their local communities “This multi-country project required balancing local requirements with the overall goal of unification. Thanks to the clear communication and collaboration of country managers and patient engagement teams, we developed a scalable concept that works for everyone,” said Nele Brennecke, Head of Patient Engagement at FutureMeds Germany, Project Lead #ClinicalResearch #ClinicalTrials

We're looking forward to engaging in meaningful discussions at the Society for Clinical Research Sites (SCRS) European Site Solutions Summit. This year, five of our colleagues will be attending, two of them sharing their expertise as speakers on critical topics. "This event provides an invaluable platform for clinical research professionals to forge connections and share best practices. Through panel discussions and collaborative dialogues, we can explore how innovations like DCTs and AI can break down industry silos and accelerate patient-centric solutions," commented Iwona Tongbhoyai, Chief Client Solutions Officer As a speaker, Iwona will be contributing to the following sessions: 🎤 Maximizing Opportunities: How To Join A Site Network  🎤 Transatlantic Transactions: Handling US-Based Stipends Nachiket Chandak, Senior Business Development Director, will be adding value to the following discussions: 🎤 Embracing Diversity & Inclusion In Research  🎤 Collective Action: Attracting More Clinical Studies To Europe Our site teams will be represented by Rocio Diaz Sanchez, Managing Director of Spain, Angela Harnick, Site Director and Kinga Zajączkowska, Site Director, whose teams made significant progress over the years. If you or your colleagues are attending and would like to connect, send our team a connection request or a message. We look forward to meeting you in Lisbon and hope to start a dialogue with you. #ClinicalTrials #ClinicalResearch

Last day of my first SCOPE summit - will I come again? Definitely! My colleagues Cameron Glen, Nachiket Chandak and I are heading back to Europe full of positive impressions, takeaways, and ideas on how we can enhance clinical research conduct and improve solutions together with our partners. We had three exciting days in Orlando, filled with networking, exchanging expertise, solidifying current partnerships, and building new ones, all with the goal of providing Tomorrow's Medicine to Patients Today. #SCOPE #networking #patients #solutions #FutureMeds